Piedmont Investment Advisors LLC Sells 3,180 Shares of Express Scripts Holding Company (ESRX)
Piedmont Investment Advisors LLC trimmed its holdings in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 2.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 152,171 shares of the company’s stock after selling 3,180 shares during the period. Piedmont Investment Advisors LLC’s holdings in Express Scripts were worth $9,635,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also bought and sold shares of ESRX. Burt Wealth Advisors increased its stake in Express Scripts by 11.4% in the second quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock valued at $108,000 after purchasing an additional 174 shares in the last quarter. CKW Financial Group increased its stake in Express Scripts by 20.0% in the second quarter. CKW Financial Group now owns 1,800 shares of the company’s stock valued at $115,000 after purchasing an additional 300 shares in the last quarter. Bank of Nova Scotia Trust Co. bought a new stake in Express Scripts in the third quarter valued at approximately $120,000. First Personal Financial Services increased its stake in Express Scripts by 199.1% in the second quarter. First Personal Financial Services now owns 2,103 shares of the company’s stock valued at $134,000 after purchasing an additional 1,400 shares in the last quarter. Finally, Financial Management Professionals Inc. increased its stake in Express Scripts by 140.1% in the second quarter. Financial Management Professionals Inc. now owns 2,334 shares of the company’s stock valued at $149,000 after purchasing an additional 1,362 shares in the last quarter. 88.44% of the stock is owned by institutional investors and hedge funds.
In other news, VP Phyllis S. Anderson sold 643 shares of the stock in a transaction on Wednesday, November 1st. The shares were sold at an average price of $62.37, for a total transaction of $40,103.91. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Timothy C. Wentworth bought 8,000 shares of Express Scripts stock in a transaction that occurred on Tuesday, October 31st. The shares were acquired at an average price of $61.13 per share, with a total value of $489,040.00. Following the acquisition, the chief executive officer now directly owns 98,628 shares of the company’s stock, valued at approximately $6,029,129.64. The disclosure for this purchase can be found here. 0.68% of the stock is owned by corporate insiders.
Several brokerages have commented on ESRX. Robert W. Baird reaffirmed a “hold” rating and issued a $56.00 target price on shares of Express Scripts in a research note on Friday, September 1st. Jefferies Group reaffirmed a “buy” rating on shares of Express Scripts in a research note on Thursday, October 26th. Zacks Investment Research raised shares of Express Scripts from a “hold” rating to a “buy” rating and set a $64.00 target price for the company in a research note on Monday, October 16th. Sanford C. Bernstein raised shares of Express Scripts from an “underperform” rating to a “market perform” rating in a research note on Wednesday, December 6th. Finally, ValuEngine downgraded shares of Express Scripts from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Six analysts have rated the stock with a sell rating, eleven have issued a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $70.67.
Shares of Express Scripts Holding Company (ESRX) opened at $68.56 on Wednesday. The company has a current ratio of 0.73, a quick ratio of 0.61 and a debt-to-equity ratio of 0.86. Express Scripts Holding Company has a 12-month low of $55.80 and a 12-month high of $73.52. The stock has a market cap of $38,734.25, a price-to-earnings ratio of 10.00, a PEG ratio of 1.01 and a beta of 0.88.
Express Scripts (NASDAQ:ESRX) last issued its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.90. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. The company had revenue of $24.68 billion during the quarter, compared to the consensus estimate of $25.68 billion. During the same quarter in the prior year, the firm earned $1.74 earnings per share. The firm’s revenue was down 2.9% compared to the same quarter last year. research analysts expect that Express Scripts Holding Company will post 7.01 EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: “Piedmont Investment Advisors LLC Sells 3,180 Shares of Express Scripts Holding Company (ESRX)” was first reported by Watch List News and is owned by of Watch List News. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The legal version of this story can be read at https://www.watchlistnews.com/piedmont-investment-advisors-llc-sells-3180-shares-of-express-scripts-holding-company-esrx/1760775.html.
About Express Scripts
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with Analyst Ratings Network's FREE daily email newsletter.